Multiprofile Hospital For Active Treatment St. Ivan Rilski Razgrad AD

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• COPD2 trials
• Asthma1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Chiesi Farmaceutici S.p.A.2 trials
• Hoffmann-La Roche1 trial

Running trials

• Recruiting

  Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma

  NCT07301736· Phase 2· Chiesi Farmaceutici S.p.A.· Source

Closed trials

• Completed

  A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05595642· Phase 3· Hoffmann-La Roche· Source

• Completed

  A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD

  NCT04320342· Phase 3· Chiesi Farmaceutici S.p.A.· Source